CLINICAL TRIALS PROFILE FOR VAPRISOL
✉ Email this page to a colleague
All Clinical Trials for VAPRISOL
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00057356 ↗ | Safety and Efficacy Study of YM087 (Conivaptan) in Patients With Acute Decompensated Heart Failure | Completed | Cumberland Pharmaceuticals | Phase 2 | 2002-11-01 | This is a randomized, double-blind, placebo-controlled, dose ranging pilot study to examine the effects of conivaptan in patients with acute decompensated heart failure. |
NCT00379847 ↗ | An Open-Label Study of YM087 (Conivaptan) in Patients With Euvolemic or Hypervolemic Hyponatremia | Completed | Cumberland Pharmaceuticals | Phase 3 | 2004-02-01 | This study will investigate the application of a vasopressin antagonist in the treatment of hyponatremia most likely caused by inappropriate AVP secretion. The population studied will include patients with euvolemic or hypervolemic hyponatremia. |
NCT00435591 ↗ | A Study of Multiple Dosing Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia | Completed | Cumberland Pharmaceuticals | Phase 4 | 2007-01-01 | The study will evaluate the effectiveness and safety of multiple dosing regimens of IV conivaptan in subjects with euvolemic or hypervolemic hyponatremia |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for VAPRISOL
Condition Name
Clinical Trial Locations for VAPRISOL
Trials by Country
Clinical Trial Progress for VAPRISOL
Clinical Trial Phase
Clinical Trial Sponsors for VAPRISOL
Sponsor Name